Skip to main content
logo
Hemogenyx Pharmaceuticals Plc (LON:HEMO)
London flag London · Delayed Price · Currency is GBP · Price in GBX
520.00
-40.00 (-7.14%)
Sep 4, 2026, 4:35 PM GMT

Hemogenyx Pharmaceuticals Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
353514271318
Market Cap Growth
-2.09%143.47%-47.51%108.28%-29.33%-56.10%
Enterprise Value
3636152779
Last Close Price
5.205.724.059.205.307.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
30.9030.1916.639.724.002.25
P/TBV Ratio
34.8934.1033.7811.514.582.37

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.751.753.071.061.060.00
Net Debt / Equity Ratio
0.370.372.890.610.27-0.84
Net Debt / EBITDA Ratio
-0.06-0.06-0.48-0.27-0.162.61
Net Debt / FCF Ratio
-0.12-0.12-0.59-0.27-0.272.09
Quick Ratio
1.091.090.141.693.4019.41
Current Ratio
1.381.380.722.933.4720.23
Return on Equity (ROE)
-977.72%-977.72%-309.56%-222.31%-69.88%-112.98%
Return on Assets (ROA)
-103.92%-103.92%-65.14%-61.24%-44.28%-30.20%
Return on Capital Employed (ROCE)
-257.70%-257.70%-176.10%-120.50%-87.20%-33.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-27.60%-28.24%-39.59%-24.75%-30.65%-27.76%
FCF Yield
-9.76%-9.99%-29.26%-23.02%-25.72%-17.77%
Buyback Yield / Dilution
-34.57%-34.57%-16.95%-15.25%-26.59%-86.57%